BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simons BC, Spradling PR, Bruden DJ, Zanis C, Case S, Choromanski TL, Apodaca M, Brogdon HD, Dwyer G, Snowball M, Negus S, Bruce MG, Morishima C, Knall C, McMahon BJ. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen. J Infect Dis. 2016;214:273-280. [PMID: 27056956 DOI: 10.1093/infdis/jiw142] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Rosa Duque JS, Wang X, Leung D, Cheng SMS, Cohen CA, Mu X, Hachim A, Zhang Y, Chan SM, Chaothai S, Kwan KKH, Chan KCK, Li JKC, Luk LLH, Tsang LCH, Wong WHS, Cheang CH, Hung TK, Lam JHY, Chua GT, Tso WWY, Ip P, Mori M, Kavian N, Leung WH, Valkenburg S, Peiris M, Tu W, Lau YL. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents. Nat Commun 2022;13:3700. [PMID: 35764637 DOI: 10.1038/s41467-022-31485-z] [Reference Citation Analysis]
2 Van Damme P, Dionne M, Leroux-Roels G, Van Der Meeren O, Di Paolo E, Salaun B, Surya Kiran P, Folschweiller N. Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. J Viral Hepat. 2019;26:1066-1075. [PMID: 31087382 DOI: 10.1111/jvh.13125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
3 Jacobson IM, Brown RS Jr, McMahon BJ, Perrillo RP, Gish R. An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus. J Clin Gastroenterol 2022. [PMID: 35389923 DOI: 10.1097/MCG.0000000000001695] [Reference Citation Analysis]
4 Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? Hum Vaccin Immunother 2018;14:456-63. [PMID: 29083945 DOI: 10.1080/21645515.2017.1397243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
5 Abara WE, Collier MG, Teshale EH. Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015. Vaccine 2017;35:997-1000. [PMID: 28117171 DOI: 10.1016/j.vaccine.2017.01.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kiertscher SM, Gangalum PR, Ibrahim G, Tashkin DP, Roth MD. A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol 2018;13:219-29. [PMID: 29340893 DOI: 10.1007/s11481-018-9776-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
7 Hess L, Riesenberg K, Rolston KVI, Nesher L. Administering an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers. Infect Dis (Lond) 2020;52:330-5. [PMID: 31983251 DOI: 10.1080/23744235.2020.1718201] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhong S, Liu Z, Zhou Y, Zhang T, Fu X, Guo L, Gu S, Tang L, Hou J, Li Y. Longitudinal mapping of hepatitis B vaccine-induced B-cell linear epitopes in healthy individuals. J Med Virol 2022. [PMID: 35676468 DOI: 10.1002/jmv.27926] [Reference Citation Analysis]
9 Osiowy C. From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity. Hum Vaccin Immunother 2018;14:2093-7. [PMID: 29641290 DOI: 10.1080/21645515.2018.1462428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
10 Santoro JD, Saucier LE, Tanna R, Wiegand SE, Pagarkar D, Tempchin AF, Khoshnood M, Ahsan N, Van Haren K. Inadequate Vaccine Responses in Children With Multiple Sclerosis. Front Pediatr 2021;9:790159. [PMID: 34926358 DOI: 10.3389/fped.2021.790159] [Reference Citation Analysis]
11 Xu B, Zhu D, Bi Y, Wang Y, Hu Y, Zhou YH. Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy. Vaccine 2017;35:2457-62. [PMID: 28320591 DOI: 10.1016/j.vaccine.2017.03.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Konopleva MV, Borisova VN, Sokolova MV, Semenenko TA, Suslov AP. Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro. Vaccines 2022;10:235. [DOI: 10.3390/vaccines10020235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67:1-31. [PMID: 29939980 DOI: 10.15585/mmwr.rr6701a1] [Cited by in Crossref: 216] [Cited by in F6Publishing: 201] [Article Influence: 54.0] [Reference Citation Analysis]
14 Vakili ME, Faghih Z, Sarvari J, Doroudchi M, Hosseini SN, Kabelitz D, Kalantar K. Lower frequency of T stem cell memory (TSCM) cells in hepatitis B vaccine nonresponders. Immunol Res 2022. [PMID: 35445310 DOI: 10.1007/s12026-022-09278-9] [Reference Citation Analysis]
15 Palacpac NMQ, Horii T. Malaria vaccines: facing unknowns. F1000Res 2020;9:F1000 Faculty Rev-296. [PMID: 32399189 DOI: 10.12688/f1000research.22143.1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wong RJ, Gish RG, Cheung R, Chitnis AS. Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease. Am J Med 2021;134:882-92. [PMID: 33775642 DOI: 10.1016/j.amjmed.2021.02.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Scheifele DW. Will Infant Hepatitis B Immunization Protect Adults? Pediatr Infect Dis J 2019;38:S64-6. [PMID: 31205248 DOI: 10.1097/INF.0000000000002326] [Reference Citation Analysis]
18 Zhou Y, Hu Y, Liu X, Yang H. CSOG MFM Committee Guideline: Management of Hepatitis B During Pregnancy and Prevention of Mother-to-Child Transmission of Hepatitis B Virus (2020). Maternal-Fetal Medicine 2021;3:7-17. [DOI: 10.1097/fm9.0000000000000087] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sagnelli C, Sagnelli E. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World J Clin Infect Dis 2019; 9(2): 11-22 [DOI: 10.5495/wjcid.v9.i2.11] [Cited by in CrossRef: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Vesikari T, Xu J, Johnson DR, Hall J, Marček T, Goveia MG, Acosta CJ, Lee AW. Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines. Hum Vaccin Immunother 2020;16:867-74. [PMID: 31689166 DOI: 10.1080/21645515.2019.1673119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 López-Gatell H, García-García L, Echániz-Avilés G, Cruz-Hervert P, Olamendi-Portugal M, Castañeda-Desales D, Sanchez-Alemán MÁ, Romero-Martínez M, DeAntonio R, Cervantes-Apolinar MY, Cortes-Alcalá R, Alpuche-Aranda C. Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) results. Hum Vaccin Immunother 2019;15:433-9. [PMID: 30380981 DOI: 10.1080/21645515.2018.1533617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hefele L, Vannachone S, Khounvisith V, Nouanthong P, Sayasone S, Kounnavong S, Chanthavilay P, Muller CP, Black AP. Lasting benefit of infant hepatitis B vaccination in adolescents in the Lao People's Democratic Republic. Int J Infect Dis 2020;93:217-23. [PMID: 32014602 DOI: 10.1016/j.ijid.2020.01.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Henry B, Baclic O; National Advisory Committee on Immunization (NACI). Summary of the NACI Update on the Recommended Use of Hepatitis B Vaccine. Can Commun Dis Rep 2017;43:104-6. [PMID: 29770073 DOI: 10.14745/ccdr.v43i05a04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
24 Phattraprayoon N, Kakheaw J, Soonklang K, Cheirsilpa K, Ungtrakul T, Auewarakul C, Mahanonda N. Duration of Hepatitis B Vaccine-Induced Protection among Medical Students and Healthcare Workers following Primary Vaccination in Infancy and Rate of Immunity Decline. Vaccines 2022;10:267. [DOI: 10.3390/vaccines10020267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tang AS, Lyu J, Wang S, He Q, Pong P, Harris AM. Disparities in Hepatitis B Virus Infection and Immunity Among New York City Asian American Patients, 1997 to 2017. Am J Public Health 2018;108:S327-35. [PMID: 30383421 DOI: 10.2105/AJPH.2018.304504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Pinto M, Dawar M, Krajden M, Naus M, Scheifele DW. Will Infant Hepatitis B Vaccination Protect Into Adulthood?: Extended Canadian Experience After a 2-, 4- and 6-month Immunization Schedule. Pediatr Infect Dis J 2017;36:609-15. [PMID: 28134742 DOI: 10.1097/INF.0000000000001543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
27 Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70:1-187. [PMID: 34292926 DOI: 10.15585/mmwr.rr7004a1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Jan CF, Liu TH, Ho CH, Chien YC, Chang CJ, Guo FR, Huang KC. Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen. Fam Pract 2020;37:30-5. [PMID: 31375819 DOI: 10.1093/fampra/cmz039] [Reference Citation Analysis]
29 Joshi SS, Davis RP, Ma MM, Tam E, Cooper CL, Ramji A, Kelly EM, Jayakumar S, Swain MG, Jenne CN, Coffin CS. Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD). NPJ Vaccines 2021;6:9. [PMID: 33431890 DOI: 10.1038/s41541-020-00266-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Komatsu H, Klenerman P, Thimme R. Discordance of hepatitis B vaccination policies for healthcare workers between the USA, the UK, and Germany. Hepatol Res 2020;50:272-82. [DOI: 10.1111/hepr.13470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ahonen A, Zhang Y, Marček T, Lumley J, Johnson DR, Guris D, Wilck MB. Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously. Hum Vaccin Immunother 2022;:2073747. [PMID: 35653552 DOI: 10.1080/21645515.2022.2073747] [Reference Citation Analysis]
32 Bruce MG, Bruden D, Hurlburt D, Morris J, Bressler S, Thompson G, Lecy D, Rudolph K, Bulkow L, Hennessy T, Simons BC, Weng MK, Nelson N, McMahon BJ. Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose. Hepatology 2022. [PMID: 35320592 DOI: 10.1002/hep.32474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Hustache S, Moyroud L, Goirand L, Epaulard O. Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage. Eur J Clin Microbiol Infect Dis 2017;36:1483-9. [PMID: 28285330 DOI: 10.1007/s10096-017-2957-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
34 Connell AR, Connell J, Leahy TR, Hassan J. Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines? Front Immunol 2020;11:2089. [PMID: 33072071 DOI: 10.3389/fimmu.2020.02089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ben Hadj M, Bouguerra H, Saffar F, Chelly S, Hechaichi A, Talmoudi K, Bahrini A, Chouki T, Hazgui O, Hannachi N, Letaief H, Bellali H, Bahri O, Ben-Alaya-Bouafif N. Observational study of vaccine effectiveness 20 years after the introduction of universal hepatitis B vaccination in Tunisia. Vaccine 2018;36:5858-64. [PMID: 30145100 DOI: 10.1016/j.vaccine.2018.08.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]